Share Email Print

Proceedings Paper

Soft lithography and surface chemistry: enabling tools for new bioassays
Author(s): Bernardo D. Aumond; Oliver Schueller; David Duffy; Emanuele Ostuni; Enoch Kim; Aaron Raphel; Christian Hodneland; Stewart Campbell; Gregory Kirk
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

The process of drug discovery can be accelerated by increasing the information content of bioassays and by employing assay platforms that are amenable to high throughput screening techniques. In this paper, we demonstrate how the combination of soft lithography with controlled surface chemistry achieves these goals in a wide spectrum of bioassays. A number of soft lithographic methods can be used to generate micro-structures for the purposes of increasing assay density, diversity of test conditions and improving assay detection qualities. In addition, soft lithography, combined with specific surface chemistry modification procedures and protein engineering, may be used to control the localized molecular and biological properties of substrates, thereby enabling the development of new types of bioassays. The developed methodologies are simple, easily implemented, and lend themselves well to automation. Experimental results and prototypes are presented to illustrate the capabilities of these new techniques. For example, soft lithography and surface chemistry are employed for chemically patterning substrates, stenciling biological entities onto substrates and confining solutions. As a result, information-rich, highdensity bioassays can be obtained where biological targets, surface properties and medium solutions are carefully determined and controlled.

Paper Details

Date Published: 21 June 2002
PDF: 8 pages
Proc. SPIE 4626, Biomedical Nanotechnology Architectures and Applications, (21 June 2002); doi: 10.1117/12.491185
Show Author Affiliations
Bernardo D. Aumond, Surface Logix, Inc. (United States)
Oliver Schueller, Surface Logix, Inc. (United States)
David Duffy, Surface Logix, Inc. (United States)
Emanuele Ostuni, Surface Logix, Inc. (United States)
Enoch Kim, Surface Logix, Inc. (United States)
Aaron Raphel, Surface Logix, Inc. (United States)
Christian Hodneland, Surface Logix, Inc. (United States)
Stewart Campbell, Surface Logix, Inc. (United States)
Gregory Kirk, Surface Logix, Inc. (United States)

Published in SPIE Proceedings Vol. 4626:
Biomedical Nanotechnology Architectures and Applications
Raymond P. Mariella; Michelle Palmer; Darryl J. Bornhop; Darryl J. Bornhop; Ramesh Raghavachari; Shuming Nie; Ramesh Raghavachari; Catherine J. Murphy; David A. Dunn; David A. Dunn; Raymond P. Mariella; Catherine J. Murphy; Dan V. Nicolau; Shuming Nie; Michelle Palmer; Ramesh Raghavachari, Editor(s)

© SPIE. Terms of Use
Back to Top